Zymeworks Inc (ZYME)
8.825
+0.12
(+1.32%)
USD |
NASDAQ |
Apr 23, 13:38
Zymeworks Cash from Investing (TTM): -207.25M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -207.25M |
September 30, 2023 | -227.98M |
June 30, 2023 | -251.39M |
March 31, 2023 | -212.64M |
December 31, 2022 | -53.85M |
September 30, 2022 | -33.64M |
June 30, 2022 | 39.15M |
March 31, 2022 | 88.32M |
December 31, 2021 | 144.60M |
September 30, 2021 | 189.85M |
June 30, 2021 | 185.07M |
March 31, 2021 | 238.18M |
December 31, 2020 | -43.44M |
September 30, 2020 | -175.04M |
June 30, 2020 | -235.40M |
Date | Value |
---|---|
March 31, 2020 | -252.37M |
December 31, 2019 | -25.59M |
September 30, 2019 | 26.59M |
June 30, 2019 | 36.06M |
March 31, 2019 | -99.58M |
December 31, 2018 | -109.05M |
September 30, 2018 | -88.56M |
June 30, 2018 | -76.65M |
March 31, 2018 | -24.94M |
December 31, 2017 | -30.89M |
September 30, 2017 | -18.09M |
June 30, 2017 | -18.33M |
March 31, 2017 | -18.86M |
December 31, 2016 | -25.45M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-252.37M
Minimum
Mar 2020
238.18M
Maximum
Mar 2021
-40.57M
Average
-33.64M
Median
Sep 2022
Cash from Investing (TTM) Benchmarks
Emergent BioSolutions Inc | 212.30M |
MariMed Inc | -25.98M |
Viemed Healthcare Inc | -52.11M |
NovaBay Pharmaceuticals Inc | -0.019M |
Palatin Technologies Inc | 9.293M |